Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter from the US Food and Drug Administration (FDA) on the heels of a routine...more
1/15/2025
/ Clinical Trials ,
Compliance ,
Corporate Governance ,
Data Integrity ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Pharmaceutical Industry ,
Regulatory Authority ,
Regulatory Requirements ,
Securities Regulation ,
Shareholders ,
Warning Letters